Related references
Note: Only part of the references are listed.Clinical Prediction of Failure of Lamivudine Prophylaxis for Hepatitis B Virus-Infected Patients Undergoing Cytotoxic Chemotherapy for Malignancy
In Kyoung Kim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Fatal hepatitis B reactivation treated with entecavir in an isolated anti-HBs positive lymphoma patient: A case report and literature review
Rosa Ferreira et al.
SAUDI JOURNAL OF GASTROENTEROLOGY (2012)
Reactivation of Hepatitis B Virus After Rituximab-Containing Treatment in Patients With CD20-Positive B-Cell Lymphoma
Kosei Matsue et al.
CANCER (2010)
Hepatitis B Virus Reactivation After 23 Months of Rituximab-based Chemotherapy in an HBsAg-negative, Anti-HBs-positive Patient With Follicular Lymphoma
I-Cheng Lee et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2010)
Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier
N. Fukushima et al.
ANNALS OF ONCOLOGY (2009)
Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab
Winnie Yeo et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Lamivudine treatment improves the prognosis of fulminant hepatitis B
Yasuhiro Miyake et al.
INTERNAL MEDICINE (2008)
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience
HL Tillmann et al.
JOURNAL OF VIRAL HEPATITIS (2006)
The use of lamivudine for patients with acute hepatitis B (a series of cases)
LA Kondili et al.
JOURNAL OF VIRAL HEPATITIS (2004)
Lamivudine treatment for acute severe hepatitis B: a pilot study
H Schmilovitz-Weiss et al.
LIVER INTERNATIONAL (2004)
Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes
H Norder et al.
INTERVIROLOGY (2004)
De novo infection in a renal transplant recipient caused by novel mutants of hepatitis B virus despite the presence of protective anti-hepatitis B surface antibody
MG Lu et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy
MF Yuen et al.
HEPATOLOGY (2001)
Share Paper
